[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$bioa
$BIOA sees positive sentiment with Leqembi's approval in China and upcoming FDA catalyst dates. Community engagement is up, with a focus on biotech stocks and potential catalysts.
About $bioa
Social media analysis of $BIOA, likely a stock ticker symbol for a biotechnology company.
Engagements: XXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
1-Year High: XXXXXX on 2025-08-29
1-Year Low: X on 2025-06-01
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-05-26
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $bioa in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: XX
1 Month: X -XX%
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-05-26
The most influential creators that mention $bioa in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @LTbioinvestor | X | XXXXXX | X | XX |
Sentiment: XXX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +50%
1-Year High: XXX% on 2025-05-20
1-Year Low: XX% on 2025-08-13
Most Supportive Themes
- FDA Approvals and Catalysts: (40%) Posts highlight upcoming FDA PDUFA dates and potential catalysts for $BIOA.
- Alzheimer's Disease Treatment: (30%) Positive sentiment around Leqembi's approval for maintenance treatment in China.
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | XX% | XX | XX% | X | X% |
| Total | XX | XX% | XX | XX% | X | X% |
Top assets mentioned In the posts about $bioa in the last XX hours
Intellia Therapeutics, Inc (NTLA) Sanofi (SNY) ROGin AI (ROG) Cytokinetics Inc. (CYTK) Mineralys Therapeutics, Inc. Common Stock (MLYS) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) United Therapeutics, Corp. (UTHR) Alphabet Inc Class A (GOOGL) Novo-Nordisk (NVO) Vertex Protocol (VRTX)
Top topics mentioned In the posts about $bioa in the last XX hours
stocks healthcare, $esaiy, $4523t, $ntla, united states, $vtyx, sanofi, $rog, stocks, $cytk, $mlys, $bhvn, united therapeutics corp, $googl, stocks communication services, $ampx, $mdxh, $sepn, $nvo, vertex protocol, china, $esalf, biogen inc, $pali, $nktr, $sdgr
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@StonkChris Consider #biotechs also way below historical highs . $ntla $pali $nktr $bioa $sdgr $crsp $prme $crnx $bhvn . just to name some"
X Link @LTbioinvestor 2025-10-08T13:01Z 17.1K followers, XXX engagements
"👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼👇🏼 $BIOA $ESAIY $ESALF $BIIB @bioarcticab @eisaiusneuro @biogen #Bioarctic #AlzheimersDisease #Leqembi #lecanemab #ParkinsonsDisease #exidavnemab #ALS"
X Link @larsen210 2025-10-08T06:27Z XXX followers, XX engagements
"💼 $GOOGL Google $AMPX Amprius Technologies $NTLA Intellia Therapeutics $MDXH MDxHealth $AIRO Airo Group $OSSD OssDsign $SGMO Sangamo Therapeutics $SRPT Sarepta Therapeutics $NKTR Nektar Therapeutics $MCLAIR Medclair $NOVO Novo Nordisk $BIOA BioArctic"
X Link @Drbagholders 2025-10-07T17:22Z XXX followers, 1283 engagements
"$BIOA $ESAIY Leqembi Iqlik (lecanemab-irmb) maintenance treatment launched in the United States BioArctic partner Eisai launched Leqembi Iqlik (lecanemab-irmb) subcutaneous autoinjector in the U.S. on October X 2025 as a maintenance option for early Alzheimers disease (MCI or mild dementia) after an initial 18-month IV induction. After XX months of XX mg/kg IV every two weeks patients may continue IV every four weeks or switch to a weekly XXX mg at-home subcutaneous injection. The company also launched a Leqembi Companion program with nurse education financial/insurance support an injection"
X Link @MarcJacksonLA 2025-10-06T22:49Z 7555 followers, XXX engagements